Surgical Critical Care at the Epicenter of the COVID-19 Pandemic

Abstract

The number of deaths and infected people by Corona-19 virusin 2020 around the world is alarming and numbing at the same time. It almostdifficult to remember when the world was normal, although it just started fewmonths ago. Our world and everything around have changed, our surgical practicehas changed, our life has changed, but Intensive Care Units (ICU)in WestchesterMedical center in Valhalla, NY, continue to care for the sickest of thesickest. But this time, different disease with different prognosis. Everycritical care specialist, every surgery resident and surgical critical carefellow, are COVID-19 doctors. As I round in the ICU, I imagine myself in one ofthose beds that I could have been few weeks ago. Now, fully recovered fromCOVID-19, and coming back to work is a real treat. Yet, I still have morequestions than answers.

Keywords

COVID-19 pandemic mortality intensive critical care tracheostomy epicenter

Get full access to this article

View all access options for this article.

References

Michetti

CP.

Burlew

CC.

Bulger

et al. Performing tracheostomy during the Covid-19 pandemic: guidance and recommendations from the Critical Care and Acute Care Surgery Committees of the American Association for the Surgery of Trauma. Trauma Surg Acute Care Open. 2020;5(1):e000482. doi:10.1136/tsaco-2020-000482

http://www.ncbi.nlm.nih.gov/pubmed/32368620

Prabhakaran

Ryan

Choi

et al. Minimizing aerosolization during open tracheostomy for Covid-19 positive patients. J Trauma Acute Care Surg. 2020. [Epub ahead of print].

Wang

Mao

. Cytokine storm in COVID-19 and treatment. J Infect. 2020;S0163-4453(20):30165-1.

Mehta

McAuley

DF.

Brown

et al. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. 2020;395(10229):1033-1034.doi:10.1016/S0140-6736(20)30628-0

http://www.ncbi.nlm.nih.gov/pubmed/32192578

Ritchie

AI.

Singanayagam

. Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? The Lancet. 2020;395(10230):1111.doi:10.1016/S0140-6736(20)30691-7

Barry

. The Great Influenza: The Epic Story of the Deadliest Plague in History. Viking Press; 2004.

Crosby

. America’s Forgotten Pandemic: The Influenza of 1918. Cambridge University Press; 1989.

Jester

Uyeki

TM.

Jernigan

DB.

Tumpey

. Historical and clinical aspects of the 1918 H1N1 pandemic in the United States. Virology. 2019;527:32-37.doi:10.1016/j.virol.2018.10.019

http://www.ncbi.nlm.nih.gov/pubmed/30453209

Jester

Uyeki

Jernigan

. Readiness for responding to a severe pandemic 100 years after 1918. Am J Epidemiol. 2018;187(12):2596-2602.doi:10.1093/aje/kwy165

http://www.ncbi.nlm.nih.gov/pubmed/30102376

10.

WHO characterizes COVID-19 as a pandemic . World Health Organization. Accessed on March 29, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen

11.

Zhu

Zhang

Wang

et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733.doi:10.1056/NEJMoa2001017

http://www.ncbi.nlm.nih.gov/pubmed/31978945

12.

Guan

et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-1207.doi:10.1056/NEJMoa2001316

http://www.ncbi.nlm.nih.gov/pubmed/31995857

13.

JT.

Leung

. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395(10225):689-697.doi:10.1016/S0140-6736(20)30260-9

http://www.ncbi.nlm.nih.gov/pubmed/32014114

14.

Centers for Disease Control and Prevention . Coronavirus disease 2019 (COVID-19). Cases in U.S. Accessed on May 7, 2020. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html

15.

WHO (World Health Organization) . International Health Regulations (2015). 2nd ed. WHO Press; 2008.

16.

Katz

Seifman

. Opportunities to finance pandemic preparedness. Lancet Glob Health. 2016;4(11):e782-e783.doi:10.1016/S2214-109X(16)30202-9

http://www.ncbi.nlm.nih.gov/pubmed/27692862

17.

Wolicki

SB.

Nuzzo

JB.

Blazes

et al. Public health surveillance: at the core of the global health security agenda. Health Secur. 2016;14(3):185-188.doi:10.1089/hs.2016.0002

http://www.ncbi.nlm.nih.gov/pubmed/27314658

18.

Spellberg

B. Dr

. William H. Stewart: mistaken or maligned? Clin Infect Dis. 2008;47(2):294.

19.

Spellberg

Taylor-Blake

. On the exoneration of Dr. William H. Stewart: debunking an urban legend. Infect Dis Poverty. 2013;2(1):3.doi:10.1186/2049-9957-2-3

20.

Centers for Disease Control and Prevention . 1918 Pandemic (H1N1 virus). Accessed on April 13, 2020. https://www.cdc.gov/flu/pandemic-resources/1918-pandemic-h1n1.html

21.

Fauci

. Infectious diseases: considerations for the 21st century. Clin Infect Dis. 2001;32(5):675-685.doi:10.1086/319235

http://www.ncbi.nlm.nih.gov/pubmed/11229834

22.

Snowden

. Epidemics and Society: From the Black Death to the Present . Yale University Press; 2019.

23.

Froes

. And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan. Pulmonology. 2020;26(2):114-115.doi:10.1016/j.pulmoe.2020.02.010

http://www.ncbi.nlm.nih.gov/pubmed/32151613

24.

Chen

Zhou

Dong

et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513.doi:10.1016/S0140-6736(20)30211-7

http://www.ncbi.nlm.nih.gov/pubmed/32007143

25.

Richardson

Hirsch

JS.

Narasimhan

et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052.doi:10.1001/jama.2020.6775

http://www.ncbi.nlm.nih.gov/pubmed/32320003

26.

R-H.

Liang

L-R.

Yang

C-Q

et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55(5):2000524. doi:10.1183/13993003.00524-2020

http://www.ncbi.nlm.nih.gov/pubmed/32269088

27.

Baud

Nielsen-Saines

et al. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020;S1473-3099(20):30195-X. doi:10.1016/S1473-3099(20)30195-X

http://www.ncbi.nlm.nih.gov/pubmed/32171390

28.

Mizumoto

Chowell

. Estimating the risk of 2019 novel coronavirus death during the course of the outbreak in China, 2020. medRxiv. 2020 [Preprint].

29.

Dietz

Santos-Burgoa

. Obesity and its implications for COVID-19 mortality. Obesity. 2020;28(6):1005.doi:10.1002/oby.22818

http://www.ncbi.nlm.nih.gov/pubmed/32237206

30.

Lippi

Wong

Henry

. Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020. [Epub ahead of print].doi:10.20452/pamw.15272

31.

Verity

Okell

LC.

Dorigatti

et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;S1473-3099(20):669-677.doi:10.1016/S1473-3099(20)30243-7

http://www.ncbi.nlm.nih.gov/pubmed/32240634

32.

Kang

Y-J

. Mortality rate of infection with COVID-19 in Korea from the perspective of underlying disease. Disaster Med Public Health Prep. 2020:1-3.doi:10.1017/dmp.2020.60

http://www.ncbi.nlm.nih.gov/pubmed/32228738

33.

Hanff

TC.

Harhay

MO.

Brown

TS.

Cohen

JB.

Mohareb

. Is there an association between COVID-19 mortality and the renin-angiotensin system-a call for epidemiologic investigations. Clin Infect Dis. 2020;ciaa329. doi:10.1093/cid/ciaa329

http://www.ncbi.nlm.nih.gov/pubmed/32215613

34.

Shahid

Kalayanamitra

McClafferty

et al. COVID-19 and older adults: what we know. J Am Geriatr Soc. 2020;68(5):926-929 [Epub ahead of print].doi:10.1111/jgs.16472

http://www.ncbi.nlm.nih.gov/pubmed/32255507

35.

Henry

BM.

de Oliveira

MHS.

Benoit

Plebani

Lippi

. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020 [Epub ahead of print].doi:10.1515/cclm-2020-0369 10 Apr 2020.http://www.ncbi.nlm.nih.gov/pubmed/32286245

36.

Liu

Chen

et al. Neutrophil-To-Lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;S0163-4453(20):30208-5. doi:10.1016/j.jinf.2020.04.002

32283162

37.

Dorn

Avan.

Cooney

RE.

Sabin

. COVID-19 exacerbating inequalities in the US. The Lancet. 2020;395(10232):1243-1244.doi:10.1016/S0140-6736(20)30893-X

http://www.ncbi.nlm.nih.gov/pubmed/32305087

38.

Indian Health Service (HIS) . Coronavirus (COVID-19). Accessed on April 19, 2020. https://www.ihs.gov/coronavirus/

39.

de Jager

Levine

AA.

Udyavar

et al. Disparities in surgical access: a systematic literature review, conceptual model, and evidence map. J Am Coll Surg. 2019;228(3):276-298.doi:10.1016/j.jamcollsurg.2018.12.028

http://www.ncbi.nlm.nih.gov/pubmed/30803548

40.

Torain

MJ.

Maragh-Bass

AC.

Dankwa-Mullen

et al. Surgical disparities: a comprehensive review and new conceptual framework. J Am Coll Surg. 2016;223(2):408-418.doi:10.1016/j.jamcollsurg.2016.04.047

http://www.ncbi.nlm.nih.gov/pubmed/27296524

41.

Carnethon

MR.

Howard

et al. Cardiovascular health in African Americans: a scientific statement from the American heart association. Circulation. 2017;136(21):e393-e423.doi:10.1161/CIR.0000000000000534

http://www.ncbi.nlm.nih.gov/pubmed/29061565

42.

Yancy

. Cardiovascular disease disparities: the gap remains. JAMA Cardiol. 2018;3(12):1183.doi:10.1001/jamacardio.2018.4040

http://www.ncbi.nlm.nih.gov/pubmed/30484829

43.

Hall

Moonesinghe

Bouye

Penman-Aguilar

et al. Racial/ethnic disparities in mortality: contributions and variations by rurality in the United States, 2012–2015. Int J Environ Res Public Health. 2019;16(3):436. doi:10.3390/ijerph16030436

44.

El-Hamamsy

Brinster

DR.

DeRose

et al. The COVID-19 pandemic and acute aortic dissections in New York: a matter of public health. J Am Coll Cardiol. 2020 [Epublished].doi:10.1016/j.jacc.2020.05.022

http://www.ncbi.nlm.nih.gov/pubmed/32422182